Atlas Trials

Effect of Nasal Steroid in the Treatment of Anosmia Due to COVID-19 Disease

Clinical trial NCT04569825 · UNKNOWN

Trial details

NCT number
NCT04569825
Sponsor
University Of Anbar
Status
UNKNOWN
Phase
Early Phase 1
Study type
INTERVENTIONAL
Clinical Trial
Start date
2020-08-01
Primary completion
2020-09-30
Enrollment
250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.